Related by context. All words. (Click for frequent words.) 83 placebo p 74 p = #.# [004] 73 mcg QD 73 statistically significant p = 73 P = .# 72 achieved ACR# 72 p = #.# [002] 72 placebo 71 p = 71 lispro 71 statistically significant p 70 mg QD 70 #.#/#.# mmHg [001] 70 P ≤ 70 #mg/day [002] 70 oxycodone CR 70 chlorambucil 70 tolterodine ER 70 confidence interval CI 70 lopinavir r arm 70 mcg BID 69 4mg/kg 69 clodronate 69 budesonide pMDI 69 mg p = 69 methotrexate monotherapy 69 achieved statistical significance 69 p = NS 69 titrated glipizide 69 plus methotrexate 69 #mg BID [001] 69 8mg/kg 69 urate lowering therapy 69 RLAI 68 Rating Scale MADRS 68 tirofiban 68 CI -#.# 68 5-FU/LV 68 adjunctive placebo 68 desvenlafaxine succinate 68 mg d 68 MADRS score 68 #mg/day [001] 68 #mg doses [002] 68 log# IU mL 68 TAXUS p value 68 Montgomery Asberg Depression 68 FOLFOX4 67 insulin detemir 67 p = .# [002] 67 mmHg p = 67 dapagliflozin plus 67 -#.# mg dL [002] 67 fluticasone salmeterol 67 ACTEMRA TM 67 tipranavir r 67 % Confidence Interval 67 saline placebo 67 % CI #.#-#.# [003] 67 % CI #.#-#.# [001] 67 ULORIC 67 tiotropium 67 mcg kg 67 splenectomized 66 mg dose 66 certolizumab 66 dalteparin 66 FOLFOX4 alone 66 #.#mg/dL 66 esomeprazole 66 lopinavir r 66 mg TID 66 mg ustekinumab 66 biphasic insulin aspart 66 ropivacaine 66 zolmitriptan 66 annualized relapse 66 irbesartan 66 octreotide LAR 66 plus dexamethasone 66 Xalatan R 66 FOLFIRI alone 66 quetiapine 66 tapentadol ER 66 mg qd 66 CIMZIA TM 66 -#.# mg dL [001] 66 unfractionated heparin 66 sumatriptan naproxen sodium 66 oral allopurinol 65 lumbar spine BMD 65 #mg QD [001] 65 mg kg dose 65 comparator arm 65 plus MTX 65 plus prednisone 65 ATACAND 65 #mg dose [003] 65 quetiapine risperidone 65 HDRS 65 statistical significance p 65 racemic albuterol 65 confidence interval #.#-#.# 65 adjunctive ABILIFY 65 linaclotide treated 65 Secondary endpoints included 65 abdominal pain abdominal discomfort 65 nicardipine 65 placebo dexamethasone 65 clinically meaningful improvement 65 ACR# response 65 CI #.#-#.# [002] 65 oxycodone IR 65 XIENCE V vs. 65 plus GP IIb 65 mg tid 65 #mg BID [003] 65 NPH insulin 65 abacavir lamivudine 65 #mg/kg [002] 64 pramipexole 64 cilostazol 64 etanercept 64 mitoxantrone 64 bosentan 64 HbA 1c levels 64 mcg Albuferon 64 LEXIVA r 64 solifenacin 64 HBeAg negative patients 64 severe hypoglycemic 64 doxazosin 64 CI = 64 APTIVUS r 64 mcg kg REBETOL 64 #/#.# mcg 64 IOP lowering 64 ritonavir boosted 64 salmeterol fluticasone 64 Acetate Rectal Suppositories 64 BMS p = 64 subcutaneous insulin 64 adriamycin 64 #mg dose [001] 64 μmol L 64 pooled comparator 64 potent CYP#A# inhibitors 64 median PFS 64 atorvastatin #mg 64 baseline HbA1c 64 Flu Cy 64 infliximab monotherapy 64 inactive placebo 64 splenectomized patients 64 nadolol 64 Doxil ® 64 PREZISTA ritonavir 64 mitoxantrone plus 64 x ULN 64 eszopiclone 63 CCyR 63 EC naproxen 63 alanine aminotransferase 63 atazanavir ritonavir 63 mg BID 63 receiving prophylactic anticoagulation 63 subcutaneous enoxaparin 63 oral rivaroxaban 63 IIIa inhibitor 63 rimonabant #mg 63 ug kg 63 non splenectomized 63 #ug [001] 63 NATRECOR R 63 amoxicillin clavulanate 63 beclomethasone dipropionate 63 refractory ischemia 63 lamotrigine 63 diuretic chlorthalidone 63 Psoriasis Area 63 ALVESCO 63 % CI #.#-#.# [002] 63 mg kg belimumab 63 -#.# log# copies mL 63 severe exacerbations 63 TEAEs 63 febrile neutropenia 63 Hazard Ratio = 63 Cmax 63 ziprasidone 63 adalimumab 63 sUA 63 serum urate 63 log# copies mL 63 flutamide 63 HBeAg seroconversion 63 binary restenosis 63 μg mL 63 -#.# ± [002] 63 leukopenia 63 nonresponders 63 tolvaptan 63 low dose Iluvien 63 Zometa hazard 63 p ≤ 63 nonsignificant difference 63 receiving ISENTRESS 63 morphometric vertebral fractures 63 mcg doses 63 nondiabetic patients 63 quetiapine XR 63 FUSILEV enhances 63 ARCOXIA 62 plus prednisone prednisolone 62 GERD symptom 62 #mg QD [002] 62 VELCADE melphalan 62 abciximab 62 eplerenone 62 FROVA 62 detemir 62 TAXUS Express Stent 62 glulisine 62 Expanded Disability Status 62 log# reduction 62 tolterodine 62 titrated glipizide plus 62 mEq L 62 mcg mL 62 % CI #.#-#.# [007] 62 #.#/#.# mm Hg [003] 62 rizatriptan 62 aspartate aminotransferase 62 prednisone prednisolone plus 62 μg kg 62 Montgomery Åsberg Depression 62 statistically significant reduction 62 timolol 62 severe neutropenia 62 achieved PASI 62 CIMZIA TM certolizumab pegol 62 QTcF 62 PEG Intron 62 mg + GLY 62 mmHg diastolic 62 progression TTP 62 paricalcitol 62 Apidra ® 62 Ishak fibrosis score 62 plus medroxyprogesterone acetate 62 mg orally 62 reinfarction 62 rosuvastatin #mg 62 LEXIVA 62 HBeAg positive patients 62 mg Androxal 62 BARACLUDE ® 62 % CI #.#-#.# [006] 62 discontinuations due 62 mg simvastatin 62 valsartan 62 QD dosing 62 response CCyR 62 #μg [002] 62 PANSS scores 62 adefovir 62 p = #.# [003] 62 FOLPI 62 MIRAPEX 62 gout flares 62 statistical significance p = 62 SSRI SNRI 62 glimepiride 62 plus ribavirin 62 ADAS Cog 62 budesonide formoterol 62 unfractionated heparin UFH 62 Pred Forte 62 IFN alfa 62 tamsulosin 62 isoproterenol 62 primary hypercholesterolemia 62 Secondary endpoints 62 weekly subcutaneous injections 62 IIIa inhibitors 62 ADAS cog 62 REYATAZ r arm 62 pg ml 62 pmol L 62 efavirenz EFV 62 candesartan cilexetil 62 divalproex sodium 62 zonisamide SR 62 corticosteroid dose 62 aspirin clopidogrel 62 oral vancomycin 62 Mg Uk 61 oxcarbazepine 61 receiving golimumab 61 BUPHENYL R sodium phenylbutyrate 61 CR nPR 61 biochemical relapse 61 receiving highly emetogenic 61 alanine aminotransferase ALT 61 DAPT 61 lumbar spine bone 61 CR CRu 61 mg kg 61 adalimumab Humira 61 CANCIDAS 61 receiving VICTRELIS 61 FluCAM 61 Peg IFN 61 HbA1c levels 61 interferon alfa 2b 61 β blockers 61 DAS# [002] 61 Secondary endpoints include 61 HAQ DI 61 recurrent venous thromboembolism 61 interquartile range 61 CsA 61 mmol L 61 creatinine ratio 61 pentoxifylline 61 nmol liter 61 mL/min/#.# m 2 61 Lucentis monotherapy 61 mild renal insufficiency 61 nonsignificant 61 pioglitazone 61 mg kg Hematide 61 XIENCE V PROMUS Stent 61 mcg dose 61 Hazard Ratio 61 NNT = 61 carvedilol 61 subcutaneously administered 61 systemic embolism 61 fasting plasma glucose FPG 61 levetiracetam 61 divalproex 61 venlafaxine Effexor 61 glycoprotein IIb IIIa inhibitor 61 piperacillin tazobactam 61 Pegasys ® 61 arterial thromboembolic events 61 PREZISTA r arm 61 ribavirin RBV 61 p = .# [001] 61 PEGINTRON TM 61 active comparator 61 metoprolol tartrate 61 FOLFIRI 61 ADCS CGIC 61 Lamictal XR 61 mg doses 61 mesalamine granules 61 dobutamine 61 TPV r 61 hyperphenylalaninemia HPA due 61 leuprorelin 61 Scale EDSS 61 VIIBRYD 61 Elitek 61 Median PFS 61 nortriptyline 61 ezetimibe simvastatin 61 headache nasopharyngitis 61 GP IIb IIIa inhibitors 61 nocturnal awakenings 61 pegaptanib 61 inhalations twice 61 Alzheimer Disease Assessment 61 3mg/kg 61 AUC0 61 mCi kg 61 pregabalin 61 insulin lispro 61 ximelagatran 61 PRADAXA #mg 61 COZAAR 61 TLUS 61 Crohn Disease Activity 61 noninferior 61 SGRQ 61 complete cytogenetic 61 EFFEXOR XR 61 fluorouracil 61 degarelix 61 aminotransferase elevations greater 61 CorVue ™ 61 dyspnea 61 FOLFOX 61 1mg 2mg 61 Cream USP 1 61 partial remissions 61 pg mL 61 alfuzosin 61 TDF FTC 61 idraparinux 61 definite stent thrombosis 61 BARACLUDE r 61 salmeterol fluticasone propionate 61 benazepril 61 pegylated interferon alfa 2b 61 alpha blocker 61 highly emetogenic 61 clopidogrel Plavix 61 VAPRISOL 61 beclomethasone 61 CIMZIA ™ 61 postintervention 61 bronchodilation 61 β blocker 61 Hazard Ratio HR 61 primidone 61 mcg albinterferon alfa 2b 61 tranylcypromine 61 mg Lucentis 61 acarbose 61 aPTT 61 nadroparin 61 olanzapine 61 placebo PBO 61 neostigmine 61 sirolimus eluting stent 61 adefovir treated 61 Q2W 61 PROCTOCORT ® Suppository Hydrocortisone 60 alfa 2a 60 periprocedural 60 baminercept 60 plus OBT 60 elevated transaminases 60 WOMAC pain 60 systemic corticosteroid 60 peginterferon alfa 2b 60 Engerix B 60 mL kg 60 peginterferon alfa 2a 60 5 Fluorouracil 60 CrCl 60 receiving INTRON 60 latanoprost 60 μg dose 60 NEVO ™ 60 fluticasone propionate 60 idarubicin 60 ARCALYST ® 60 ARB telmisartan 60 LVEF 60 sertraline Zoloft 60 virologic breakthrough 60 INVEGA ® 60 cabazitaxel 60 nonfatal MI 60 anemia hemoglobin 60 Perforomist Inhalation Solution 60 PASI scores 60 NIHSS 60 Thal Dex 60 DAS# remission 60 levosimendan 60 aspartate aminotransferase AST 60 olmesartan 60 LPV r 60 ruboxistaurin 60 peak plasma concentrations 60 hours postdose 60 aldosterone antagonists 60 6R BH4 60 YMRS 60 ACR# [002] 60 tobramycin inhalation solution 60 serum phosphorus 60 salmeterol inhalation powder 60 PREZISTA r 60 Timed Walk 60 citalopram 60 xanthine oxidase inhibitor 60 g dl 60 intravenous dosing 60 log# 60 alteplase 60 chlorthalidone 60 mcg linaclotide 60 dexmedetomidine 60 Score TOS 60 symptom severity 60 risperidone Risperdal 60 extrapyramidal symptoms 60 QVAR R 60 SGPT 60 cis retinoic acid 60 deep venous thromboses 60 DOXIL 60 receiving VELCADE 60 elevated ALT 60 PREMPRO 60 mmol l 60 sham injections 60 ketorolac 60 paclitaxel eluting stents 60 PSA nadir 60 HCTZ 60 prazosin 60 recurrent glioblastoma multiforme 60 timepoints 60 virologic failure 60 secondary endpoint 60 ARIXTRA 60 estramustine 60 complete cytogenetic response 60 OADs 60 Biaxin R 60 oral antidiabetic medication 60 paroxetine sertraline 60 nausea photophobia 60 dose dependently 60 hydroxymethyl coenzyme 60 somatostatin analog 60 hypomagnesemia 60 FAMPYRA 60 milrinone 60 gastric pH 60 urinary N telopeptide 60 IU mL 60 mg clopidogrel 60 conjugated equine estrogens 60 Lupuzor ™ 60 glycated hemoglobin levels 60 ug dose 60 moderate renal impairment 60 citalopram Celexa 60 pCR 60 lispro alone 60 HbA 1c 60 ARIMIDEX 60 fondaparinux 60 statistically significant improvement 60 Stent p = 60 ACR# responses 60 plasma HCV RNA 60 hour bronchodilation 60 induce orthostatic hypotension 60 enoxaparin 60 beta 1a 60 chemoradiation therapy 60 bolus injection 60 mcg kg min 60 Primary endpoints 60 cardiovascular calcification 60 International Prostate Symptom 60 coadministration 60 EDSS score 60 ß blockers 60 BRINAVESS 60 nausea somnolence 60 NIH CPSI 60 concomitant medications 60 R adefovir dipivoxil 60 zoledronate 60 mg m² 60 #mg/m# [002] 60 serum phosphorous 60 MADRS 60 goserelin 60 mg/# hours 60 Fludara 60 tadalafil Cialis 60 HAM D# scores 60 glycosylated hemoglobin HbA1c 60 clomipramine 60 haloperidol Haldol 60 FOLFOX6 60 attain statistical significance 59 H2RAs 59 aspirin heparin 59 ACE inhibitor ramipril 59 virological response 59 interferon alfa 59 ng dL 59 azathioprine 59 BENICAR HCT 59 Tarceva TM 59 trospium 59 quetiapine Seroquel 59 TMP SMX 59 mg subcutaneously 59 kilogram mg kg 59 bolus dose 59 dyspnoea 59 SUSTENNA TM 59 Lantus ® 59 nasopharyngitis 59 febuxostat 59 fluticasone 59 platelet inhibition 59 diabetic gastroparesis 59 Scale cognitive subscale 59 SSRI citalopram 59 intramuscularly 59 PANSS total 59 oblimersen 59 administered subcutaneously 59 clinically meaningful improvements 59 microbiological eradication 59 saline injections 59 drotrecogin alfa activated 59 seropositive patients 59 apremilast 59 achieved CCyR 59 uM 59 anthracycline taxane 59 alvimopan 59 atherothrombotic events 59 serum urate levels 59 CDAI 59 serologically active patients 59 selegiline 59 bivalirudin 59 dose clopidogrel 59 DAS# scores 59 MACCE 59 lanthanum carbonate 59 IR prednisone 59 CRp 59 relapsed MM 59 venlafaxine ER 59 tacrolimus ointment 59 virologic response 59 mg subcutaneous 59 dacarbazine 59 bezafibrate 59 -#.# log# 59 cerebrovascular events 59 IFN α 59 plus glycoprotein IIb 59 PEGylated anti 59 pioglitazone HCl 59 peripheral edema 59 events AEs 59 insulin glargine 59 Lamotrigine 59 Navelbine 59 ARICEPT 59 venlafaxine XR 59 6mg 59 reteplase 59 tocilizumab 59 serum concentrations 59 icatibant 59 ritonavir boosted atazanavir 59 rabeprazole 59 salmeterol HFA MDI 59 candesartan 59 overt nephropathy 59 cyclophosphamide methotrexate 59 terazosin 59 hemoglobin A1c HbA1c 59 rotigotine 59 CSBMs 59 visilizumab 59 ALIMTA cisplatin 59 nmol 59 angiotensin converting enzyme inhibitor 59 demonstrated statistically significant 59 GPIIb IIIa inhibitors 59 lowest tertile 59 8mg 59 mg RDEA# 59 pravastatin 59 #.#-#.# p = 59 creatinine clearance 59 balsalazide 59 DAS# CRP 59 aldosterone antagonist 59 metformin hydrochloride 59 EMSAM 59 dose colchicine 59 q#h 59 recurrent VTE 59 serum magnesium 59 biologic DMARD 59 mecamylamine 59 molindone 59 diameter stenosis 59 AUA Symptom Score 59 MCyR 59 -#.# p = 59 salmeterol 59 Noxafil 59 KAPIDEX 59 sUA levels 59 placebo fluoxetine 59 phenytoin 59 Aptivus ® 59 incidence ≥ 59 Carvedilol 59 ramelteon 59 imipenem 59 ramipril 59 #mg #mg #mg [003] 59 % CI #.#-#.# [008] 59 timepoint 59 T2 lesion volume 59 IM progesterone 59 bone marrow reticulin deposition 59 unresectable HCC 59 tenecteplase 59 selective modulator 59 antiandrogen 59 hypokalemia 59 posttreatment 59 stage IIIb IV 59 serum phosphate 59 MULTAQ 59 epoetin alpha 59 #mg/m# [001] 59 SVR# 59 #.#g/day 59 oral corticosteroids 59 dose dexamethasone 59 TNF Tumor Necrosis Factor 59 angiotensin converting enzyme inhibitors 59 Pharmacokinetics PK 59 noninferiority 59 docetaxel chemotherapy 59 postmenopausal osteoporotic women 59 ABC/3TC 59 LATUDA 59 hypercalcemia 59 AGILECT ® 59 ibandronate 59 MoxDuo TM IR 59 sertraline 59 mycophenolate mofetil 59 generalized edema 59 captopril 59 mg/m2 IV 59 Paxil paroxetine 59 PEG IFN 59 interferon alfa 2a 59 medroxyprogesterone acetate 59 clopidogrel 59 Mg Usa 59 docetaxel prednisone 59 postprocedure 59 liver histology 59 deferoxamine 59 TNF antagonist 59 GnRH agonist 59 CNS LS 59 Fulvestrant 59 amprenavir 59 baseline A1C 59 doxorubicin docetaxel 59 μg 59 rimonabant #mg/day 59 hypoglycemic events 59 Folfox 59 CDAI score 59 certolizumab pegol 59 Meets Primary Endpoint 59 LANTUS R 59 mRS 58 prednisone prednisolone 58 caspofungin 58 Fasting plasma glucose 58 palifermin 58 Severity MSCS score 58 rufinamide 58 tapentadol IR 58 ACR# ACR# 58 ZOMIG Nasal Spray 58 fluoxetine 58 plus gemcitabine 58 IFN beta 58 PROMACTA 58 SEROQUEL R 58 metformin HCl 58 VESIcare 58 R entecavir 58 azacitidine 58 insulin glulisine 58 CIMZIA R 58 AGILECT R 58 pulmonary exacerbation 58 activated partial thromboplastin 58 colorectal adenoma 58 LMWH 58 analgesic efficacy 58 stent binary restenosis 58 Index CDAI 58 antiarrhythmic drugs 58 composite endpoint 58 oral prednisone 58 IBDQ 58 min -1 58 thienopyridines 58 SPRYCEL ® 58 thromboembolic events 58 bivalirudin monotherapy 58 left ventricular systolic 58 5mg #mg 58 conjugated estrogens 58 microgram kg 58 Y BOCS 58 COREG 58 ALT normalization 58 ACEIs 58 ribavirin therapy 58 glargine 58 ipsilateral stroke 58 fatigue asthenia 58 lamivudine refractory patients 58 dosed orally 58 H2 receptor antagonists 58 Ramipril 58 sodium nitroprusside 58 CYP#D# inhibitor 58 KRAS mutant tumors 58 mg/m2 dose 58 EXJADE 58 5FU 58 prospectively stratified 58 mg eq 58 CONCERTA 58 1mg dose 58 mg/# mg [001] 58 weekly intravenous infusions 58 tenofovir emtricitabine 58 posaconazole 58 pamidronate 58 recurrent genital herpes 58 pegylated interferon alpha 58 anagrelide 58 oral diclofenac 58 stavudine d4T 58 treprostinil 58 serum estradiol 58 prucalopride 58 gadobutrol 58 IV bolus 58 IPSS 58 ropinirole 58 fluvastatin 58 RoACTEMRA 58 dexamethasone Decadron 58 humanized interleukin 6 58 fasting triglyceride levels 58 hypophosphatemia 58 intermittent dosing 58 Mean Symptom Complex 58 conventional DMARDs 58 serum phosphate levels 58 doripenem 58 BEACOPP 58 HAM D# 58 plasma leptin 58 Pioglitazone 58 glatiramer acetate 58 risedronate Actonel 58 galiximab 58 dose cytarabine 58 Solid Tumors criteria 58 recurrent ischemia 58 cytogenetic response 58 H2 blockers 58 undetectable viral 58 carotid intima media 58 mg/# hr 58 -#.# mmol L 58 statin monotherapy 58 Durezol 58 sustained virologic response 58 Ziprasidone 58 NOXAFIL Oral Suspension 58 tinzaparin 58 hypogonadal men 58 intravenous bolus 58 INVEGA R 58 methacholine challenge 58 relapsers 58 VIRAMUNE 58 mL/min/#.# m2 58 diastolic BP 58 peripheral sensory neuropathy 58 tegaserod 58 myelodysplastic myeloproliferative diseases 58 steroid dexamethasone 58 pegylated interferon alfa 58 glycosylated hemoglobin levels 58 serum cortisol 58 lactulose 58 SCIg 58 dizziness nausea diarrhea 58 HBeAg 58 canakinumab 58 uncoated stent 58 oxymorphone ER 58 Sinemet 58 NYHA functional class 58 EPIVIR 58 citalopram hydrobromide 58 teriparatide 58 argatroban 58 mmol kg 58 linezolid 58 events TEAEs 58 RGT arm 58 infusional 58 zoledronic acid 58 paresthesias 58 bupropion SR 58 apolipoprotein B 58 lamotrigine Lamictal 58 hip BMD 58 dose cohort 58 Known hypersensitivity 58 acute gout flares 58 IV DHE 58 postprandial glucose PPG 58 FDA defined valvulopathy 58 serum potassium 58 p = ns 58 Free Survival PFS 58 eptifibatide 58 #.#mmHg 58 Interferon beta 1b 58 symptomatic VTE 58 -#.# mm Hg 58 VaD 58 teriflunomide 58 nevirapine Viramune 58 virological failure 58 Tolvaptan 58 % tretinoin Gel 58 somnolence dizziness 58 venlafaxine 58 5mg/kg 58 esomeprazole Nexium 58 Platelet counts 58 interferon ribavirin 58 Oral Fingolimod 58 rFVIIa 58 daunorubicin 58 hepatic enzyme 58 cholinesterase inhibitor 58 Lipitor #mg 58 detectable HCV RNA 58 laxation 58 Taxus Stent 58 HbA1C levels 58 aplindore 58 mg 58 serum uric acid 58 mmHg p 58 MMX mesalamine 58 bisoprolol 58 experienced virologic failure 58 Unified Parkinson Disease 58 aprepitant 58 phonophobia 58 EMEND 58 rhGH 58 trimethoprim sulfamethoxazole 58 FEV1 58 DOXIL ® 58 APIDRA R 58 umol L 58 risperidone 58 antihypertensive therapy 58 mg dosed twice 58 mg hydrochlorothiazide 58 pretreatment baseline 58 mg BID dose 58 conjugated equine estrogen 58 neurologic progression 58 peginterferon alfa 2a #KD 58 PegIFN RBV 58 severe renal impairment 58 glycated hemoglobin HbA1c 58 milligram doses 58 BENICAR 58 CONCERTA ® 58 dose atorvastatin 58 + PH# 58 postoperative AF 58 lenalidomide dexamethasone 58 haloperidol 58 sirolimus stent 58 agomelatine 58 BUPHENYL 58 oxaliplatin Eloxatin 58 mucosal healing 58 intima media thickness 58 fluorouracil leucovorin